Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY) shares gapped up before the market opened on Wednesday. The stock had previously closed at $4.65, but opened at $4.80. Hypermarcas shares last traded at $4.80, with a volume of 1,100 shares traded.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy”.

Hypermarcas Stock Performance

The firm’s fifty day simple moving average is $4.27 and its 200 day simple moving average is $4.31. The company has a market capitalization of $3.27 billion, a price-to-earnings ratio of 9.28 and a beta of 0.71. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.86 and a quick ratio of 1.26.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 12.68%. On average, sell-side analysts forecast that Hypermarcas will post 0.53 EPS for the current year.

Hypermarcas Company Profile

Hypermarcas SA was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.

The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines.